What is the loading dose for MI patient?
Reading File
The question about loading doses in MI is broad - several drugs are given as loading doses in acute MI management. Let me clarify before diving deep.
Asking for Preferences
Which drug or drug class are you asking about the loading dose for?
Antiplatelet loading doses in acute MI: Aspirin 300 mg, Clopidogrel 300-600 mg, Ticagrelor 180 mg, Prasugrel 60 mg - all given as a single oral loading dose at presentation.
Searching sources...
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here is a clear summary of antiplatelet loading doses used in acute MI (ACS/STEMI/NSTEMI):
Antiplatelet Loading Doses in Acute MI
1. Aspirin (ASA)
- Loading dose: 162-325 mg orally (chewed for faster absorption)
- Maintenance: 75-100 mg/day (must be <100 mg/day if used with ticagrelor)
- Given to ALL patients with ACS at presentation, unless contraindicated.
2. Clopidogrel (Plavix) - P2Y12 inhibitor (prodrug)
- Loading dose: 300 mg orally (standard) or 600 mg (for faster/greater inhibition before PCI)
- 300 mg: ~80% platelet inhibition within 5 hours
- 600 mg: faster onset (useful if PCI within 3-4 hours)
- Maintenance: 75 mg/day
- Requires hepatic activation via CYP2C19; poor metabolizers may have reduced response.
- Used in both STEMI and NSTEMI.
(Katzung's Basic and Clinical Pharmacology, 16th Ed.; Rosen's Emergency Medicine)
3. Ticagrelor (Brilinta) - P2Y12 inhibitor (direct, reversible) - Preferred agent
- Loading dose: 180 mg orally
- Maintenance: 90 mg twice daily
- NOT a prodrug - works directly without hepatic conversion
- Peak concentration at ~2.5 hours
- Preferred over clopidogrel due to mortality benefit in ACS (PLATO trial)
- Note: Maintenance aspirin dose must be kept <100 mg/day when used with ticagrelor
- Relative contraindications: bradycardia, severe reactive airway disease, prior hemorrhagic stroke
(Harrison's Principles of Internal Medicine 22E; Washington Manual of Medical Therapeutics)
4. Prasugrel (Effient) - P2Y12 inhibitor (prodrug, faster than clopidogrel)
- Loading dose: 60 mg orally
- Maintenance: 10 mg/day
- Only used in the invasive approach (PCI) and only after coronary anatomy is known
- Faster, greater, and more uniform platelet inhibition vs. clopidogrel
- Absolute contraindications: prior TIA or stroke, high bleeding risk
- Use with caution: age >75 years, body weight <60 kg
- No benefit shown for pre-treatment before PCI in NSTE-ACS
(Katzung's Basic and Clinical Pharmacology; Washington Manual; Rosen's Emergency Medicine)
Quick Reference Table
| Drug | Loading Dose | Maintenance | Route | Note |
|---|---|---|---|---|
| Aspirin | 162-325 mg | 75-100 mg/day | PO (chew) | All ACS patients |
| Clopidogrel | 300-600 mg | 75 mg/day | PO | Prodrug, CYP2C19 |
| Ticagrelor | 180 mg | 90 mg BID | PO | Preferred, direct |
| Prasugrel | 60 mg | 10 mg/day | PO | PCI only, post-anatomy |
Key Clinical Points:
- DAPT (Dual Antiplatelet Therapy) = Aspirin + one P2Y12 inhibitor, is standard in all ACS patients.
- Ticagrelor is the preferred P2Y12 inhibitor in most ACS scenarios due to its mortality advantage.
- Prasugrel is reserved for patients going to the cath lab where PCI is planned, after coronary anatomy is confirmed.
- In STEMI patients unable to take oral agents (e.g., post-cardiac arrest), cangrelor (IV P2Y12 inhibitor) can be considered - it has an immediate onset (<2 minutes) and short half-life (4-6 minutes).
This is a shared conversation. Sign in to Orris to start your own chat.